FFAR3 and breast cancer: Moreover, propionate and butyrate could activate GPR41 which was coupled through Gαi/o proteins to reduce cAMP (37), increase the intracellular concentration of Ca2+, and inhibit the MAPK signaling pathway to lower the invasion of breast cancer cells (36).